PRL and breast carcinoma: Conversely, among postmenopausal women, prolactin was similarly associated with breast cancer risk regardless of pSTAT5 expression or expression of PRLR or pJAK2, suggesting that this pathway may not be the sole or even primary mechanism of action in this population.